obesity-995x60.png
FEATURED ARTICLES
Precision Medicine Needs Better Infrastructure — And We Already Have The Models For It
Standard methods for evaluating clinical trial representativeness perform poorly when the trial population differs from the broader disease population in a patient registry. June Cha, Ph.D., MPH, explains how the right metrics can make a difference.
-
![compliance, business-GettyImages-1083248970]( "Navigating The Waters Of Compliance In Clinical Research")
Navigating The Waters Of Compliance In Clinical ResearchStrengthen your research processes by adopting secure systems, staying current with regulatory standards, and ensuring your team is consistently trained to manage data responsibly and efficiently.
-
![Fda Headquarters-GettyImages-2211199138]( "Here's How FDA's Accelerated Approval Pathway Has Evolved Since '24")
Here's How FDA's Accelerated Approval Pathway Has Evolved Since '24FDA's accelerated approval guidance kicked off a rebalancing of new drug approval pathways. Since its 2024 release, the agency has been building on it in a few key areas.
-
![Business strategy-GettyImages-2255212900]( "From Hint To Headline: FOMAT Acquires Site Network")
From Hint To Headline: FOMAT Acquires Site NetworkFOMAT Medical CEO, Nick Focil, talks about the company’s acquisition of site network Topography Health — a deal that expands FOMAT’s national footprint and reflects a broader trend of site network growth aimed at scaling access, data, and operational reach.
SERVICES AND PRODUCTS
Design, build, simulate, and analyze clinical studies in one connected system. Embedded intelligence supports the full lifecycle, from protocol development to closeout.
At DVCR, our Central Laboratory Services are built for multi-site studies, combining customizable kits, next-day results and real-time shipment monitoring to keep every site aligned and on schedule. Backed by dedicated client teams, a comprehensive Central Lab Manual and rapid-response testing, we deliver the flexibility and speed your studies require.
Digital health technologies have the potential to transform clinical trials, yet without careful planning and support, their implementation can increase site burden and jeopardize data quality.
Accelerate clinical trials with expert patient recruitment strategies delivering faster enrollment, lower dropout rates, and better outcomes.
Your trusted partner for decentralized post-marketing surveillance clinical trials and real-world evidence collection. Point-of-need accessibility. Proven compliance.
Speed without shortcuts: AI in clinical development
Our vision is to develop AI solutions that enable faster delivery of new medicines to patients.
AI in Clinical Development is at the core of Parexel’s approach to accelerating first-time quality and milestone delivery through our strategic operating model, Parexel Precision Pathway. We’re committed to the development of innovative, high-value use cases for AI in clinical trials. AI empowers our people at critical decision points and our AI investments prioritize process optimizations that:
- Simplify complex tasks to accelerate timelines
- Apply insights with agility to enable better decision-making
- Enhance data handling to drive first time quality through content generation and workflow automation.